CME Group Inc.(CME)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
CME | 106.19 B | 24.07x | 0.80% | 63.44% | $12.27 | 15.80% | 0.15x | 1.76% | $329.16 | $218.31 |
SPGI | 129.16 B | 25.74x | 10.40% | 30.54% | $17.02 | 14.26% | 0.43x | 0.91% | $518.88 | $358.55 |
ICE | 89.02 B | 22.09x | 4.80% | 38.25% | $7.18 | 14.09% | 0.69x | 1.26% | $174.25 | $121.39 |
MCO | 82.32 B | 30.16x | 15.10% | 34.25% | $15.76 | 76.93% | 2.41x | 0.81% | $543.25 | $399.61 |
Peer Valuation & Performance Analysis
Peer group analysis for CME Group Inc. (CME) compared to its primary competitors (including SPGI, ICE, MCO) reveals distinct metrics. CME trades at a valuation discount relative to its competitors, with a P/E ratio of 24.1x versus the peer average of 26.0x (representing a 7% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, CME's revenue growth of 0.8% lags behind the peer average of 10.1%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 63.4% compared to the peer average of 34.3%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• CME ranks #2 in P/E ratio, #4 in revenue growth, and #1 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $296.49 | $299.92 | $293.30 | $295.31 | 3,110,749 | +0.61% |
| 2026-10-19 | $293.86 | $294.10 | $291.42 | $293.53 | 3,510,600 | -0.12% |
| 2026-10-16 | $291.68 | $293.97 | $289.50 | $293.87 | 2,180,200 | +1.52% |
| 2026-10-15 | $288.00 | $290.20 | $285.95 | $289.46 | 2,084,400 | +1.36% |
| 2026-10-14 | $278.74 | $286.59 | $278.50 | $285.59 | 2,003,500 | +2.72% |
| 2026-10-13 | $278.43 | $280.56 | $276.68 | $278.03 | 1,418,800 | +0.28% |
| 2026-10-12 | $281.78 | $283.52 | $276.38 | $277.24 | 1,601,300 | -1.18% |
| 2026-10-09 | $278.38 | $281.52 | $277.00 | $280.56 | 2,593,100 | +1.49% |
| 2026-10-08 | $270.75 | $278.21 | $269.77 | $276.44 | 3,808,100 | +2.28% |
| 2026-10-07 | $269.81 | $272.39 | $267.87 | $270.27 | 1,307,600 | +0.03% |
| 2026-10-06 | $269.43 | $272.39 | $266.81 | $270.18 | 1,373,800 | +0.06% |
| 2026-10-05 | $264.67 | $270.17 | $260.35 | $270.03 | 1,564,800 | +2.62% |
| 2026-10-02 | $265.41 | $265.41 | $260.06 | $263.14 | 1,522,400 | -0.74% |
| 2026-10-01 | $263.93 | $267.82 | $262.60 | $265.10 | 2,279,200 | +1.19% |
| 2026-09-30 | $261.86 | $264.88 | $260.49 | $261.98 | 1,903,300 | -0.47% |
Explore More Analysis for CME
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.